Latest News
GAM Investments has entered into a strategic partnership with Liberty Street Advisors (Liberty Street) to provide clients with access to leading late-stage privately-owned technology and innovation-driven companies.
In partnership with Liberty Street, GAM plans to launch a capability which will leverage the expertise of Liberty Street’s private markets investment team. This capability will give clients the opportunity to gain exposure to a market which has historically been difficult for them to access.
St Andrews-based investment firm Eos Advisory’s portfolio has reached a total valuation of GBP121 million based on latest investment rounds, and its first two exit events in 2021, including when Genus Plc acquired a large stake in aquaculture specialist Xelect.
In January 2021, Eos announced that it had led a GB{1.24 million investment into RAB-Microfluidics, an Aberdeen-headquartered R&D company developing cutting-edge microfluidic technology to diagnose engine and turbine wear in real time. Founded by CEO Rotimi Alabi, RAB-Microfluidics has since grown the team and gained significant sales.
In February 2021, Eos secured its first strategic investment partnership with US-based Kineticos
Vensica Therapeutics (Vensica), a clinical stage biopharmaceutical company, has closed a USD19 million investment round.
Vensica executed a strategic collaboration agreement with Merz Therapeutics in 2021 and the Merz Group is participating in Vensica’s financing with up to USD3 million, bringing the total round to up to USD19 million. The round was led by Israel Biotech Fund (IBF) with the participation of Laborie, Lew Pell, Agriline, and The Trendlines Group.
Merz Therapeutics, a business of the Merz Group, is a specialist in the field of neurotoxins. Vensica has exclusively licensed Merz’s botulinum neurotoxin A (Xeomin®) for needle-free use in urological
Reliance Health, an emerging markets-focused digital healthcare provider, has secured USD40 million in a Series B funding round led by General Atlantic.
Partech, Picus Capital, Tencent Exploration, AAIC (Asia Africa Investment and Consulting), P1 Ventures, Laerdal Million Lives Fund, M3, Inc, and Arvantis Social Foundation also participated.
With this funding, Reliance Health has successfully closed the largest Series B round in the African HealthTech industry to date. The newly-established partnership also marks General Atlantic’s first technology investment in Africa. To date, Reliance Health has raised USD48 million in total funding, including a USD6 million Series A funding round in January
O2 Investment Partners has appointed Andrew Faubel as the firm’s newest Jr Vice President.
Prior to joining O2, Faubel was with Crescent Cove, a TMT focused multi-strategy investment firm based in San Francisco.
Prior to that, he was with Evercore in New York and San Francisco, advising corporate clients on M&A and capital markets transactions, having begun his career at Bank of America in New York, advising institutional and ultra high net worth clients on investment strategy.
Flexport, a platform for global logistics, has closed a USD935 million Series E investment round led by Andreessen Horowitz and MSD Partners with a strategic investment from Shopify.
Elicit Plant, an AGtech company specialised in crops’ water resistance and in the development of innovative phytosterol-based solutions, announces it has raised EUR16 million in a Series A financing round.
The capital component was led by Sofinnova Partners, with the support of ECBF, Bpifrance, and historical investors, Aquiti Gestion-NACO fund and Credit-Agricole Charente Perigord Expansion, the rest of the funding came from a banking pool and public programs from Region Nouvelle Aquitaine and Bpifrance.
Elicit Plant was founded in 2017 with the ambition to become a sustainability transition champion in agriculture and respond to the global challenge of water stress
BTIG has appointed Alex Alden as a Managing Director and Head of Financial Institutions and Financial Technology within its Investment Banking division.
Alden will oversee the firm’s efforts to deliver a complete set of advisory and capital solutions to BTIG’s financial services and financial technology clients globally. In his new role with the firm, he will be based in BTIG’s San Francisco office and report to Matt Clark, Global Head of Investment Banking.
Alden brings more than 25 years of industry experience to BTIG. Most recently, he was a Managing Director and Head of Financial Institutions and Head of Financial
Litigation investment company, Henderson & Jones (H&J), has received an initial GBP5 million working capital facility from Secure Trust Bank Commercial Finance to support its growth ambitions.
H&J, which is headquartered in London with office premises in the Midlands, specialises in the purchase of claims from insolvent companies, delivering returns through effective and strategic litigation while bearing the associated cost and risk.
The firm has a track record of litigating claims up to GBP50 million and is looking to grow its successful business model. This additional capital facility will enable H&J to further expand its scope, with a focus
Innovid (NYSE: CTV), an independent connected TV (CTV) advertising delivery and measurement platform, ia to acquire TVSquared, an independent global measurement and attribution platform for converged TV, in a cash and stock transaction valued at approximately USD160 million.
With the industry calling for a more transparent and accountable TV ecosystem, the deal establishes a new currency-grade standard for cross-platform measurement, powered by the scale and automation of an independent global ad server.
Upon closing, Calum Smeaton will be stepping down as TVSquared CEO to take on a strategy role in support of the integration with Innovid. TVSquared’s president, Kinsella, who
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
